Genome-wide association studies identify<i>PRKCB</i>as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population

Minae Kawashima; Kazuhiro Sugi; Motoyuki Kohjima; Tsutomu Yamashita; Masao Honda; Yosuke Kawai; Yuki Hitomi; Yukio Ohara; Satoshi Yamagiwa; Yoko Nakamura; Takashi Himoto; Kazuhiko Nakao; Hiromasa Ohira; Hajime Ota; Makiko Taniai; Mikio Zeniya; Masataka Seike; Masaru Harada; Takeji Umemura; Kazumoto Murata; Hirotoshi Ebinuma; Satoru Joshita; Tatsuo Kanda; Hitomi Nakamura; Kaname Yoshizawa; Atsushi Tanaka; Yoshiyuki Ueno; Toyokichi Muro; Yoshihiro Aiba; Yasuhiro Miyake; Shuichi Kaneko; Hirotaka Kouno; Masanori Abe; Toshiki Komeda; Toshiki Nikami; Shotaro Sakisaka; Kaname Kojima; Masaaki Shimada; Nao Nishida; Osamu Yokosuka; Hidetaka Shibata; Nobuyoshi Fukushima; Etsuko Hashimoto; Kazuhide Yamamoto; Noboru Hirashima; Hiroshi Kouno; Takafumi Ichida; Makoto Nakamuta; Tatsuji Komatsu; Michio Senju

doi:10.1093/hmg/ddw406

Genome-wide association studies identify<i>PRKCB</i>as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population

Minae Kawashima(The University of Tokyo), Kazuhiro Sugi(Nagasaki Medical Center), Motoyuki Kohjima(Nagasaki Medical Center), Tsutomu Yamashita(Nagasaki Medical Center), Masao Honda(Kanazawa University), Yosuke Kawai(Tohoku University), Yuki Hitomi(Duke University), Yukio Ohara(Nagasaki Medical Center), Satoshi Yamagiwa(Niigata University), Yoko Nakamura(Nagasaki Medical Center), Takashi Himoto(Kagawa Prefectural College of Health Sciences), Kazuhiko Nakao(Nagasaki University Hospital), Hiromasa Ohira(Fukushima Medical University), Hajime Ota(Nagasaki Medical Center), Makiko Taniai(Tokyo Women's Medical University), Mikio Zeniya(International University of Health and Welfare), Masataka Seike(Oita University), Masaru Harada(University of Occupational and Environmental Health Japan), Takeji Umemura(Shinshu University), Kazumoto Murata(National Center for Global Health and Medicine), Hirotoshi Ebinuma(Keio University), Satoru Joshita(Shinshu University), Tatsuo Kanda(Nihon University), Hitomi Nakamura(Nagasaki Medical Center), Kaname Yoshizawa(Shinshu University), Atsushi Tanaka(Teikyo University), Yoshiyuki Ueno(Yamagata University), Toyokichi Muro(Nagasaki Medical Center), Yoshihiro Aiba(Nagasaki Medical Center), Yasuhiro Miyake(Nishinomiya Municipal Central Hospital), Shuichi Kaneko(Kanazawa University), Hirotaka Kouno(Nagasaki Medical Center), Masanori Abe(Ehime University), Toshiki Komeda(Nagasaki Medical Center), Toshiki Nikami(Nagasaki Medical Center), Shotaro Sakisaka(Fukuoka University), Kaname Kojima(Tohoku University), Masaaki Shimada(Nagasaki Medical Center), Nao Nishida(National Center for Global Health and Medicine), Osamu Yokosuka(Chiba University), Hidetaka Shibata(Nagasaki University), Nobuyoshi Fukushima(Nagasaki Medical Center), Etsuko Hashimoto(Tokyo Women's Medical University), Kazuhide Yamamoto(Okayama University), Noboru Hirashima(Nagasaki Medical Center), Hiroshi Kouno(Nagasaki Medical Center), Takafumi Ichida(Nagoya City University), Makoto Nakamuta(Nagasaki Medical Center), Tatsuji Komatsu(Nagasaki Medical Center), Michio Senju(University of Occupational and Environmental Health Japan)

Human Molecular Genetics

November 25, 2016

10.1093/hmg/ddw406

Cited by 53

Related Papers

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

|Journal of Hepatology|1999|2.9k

Simplified criteria for the diagnosis of autoimmune hepatitis†

|Hepatology|2008|1.9k

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

|Hepatology|1990|1.2k

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|720

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

|European Journal of Cancer|2011|573